CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases
Advances in Cell and Gene Therapy · 2018
DOI: 10.1002/acg2.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Cell and Gene Therapy, 2018. Verfasst von Justin S. Antony und 5 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Jürgen Manchot Stiftung, H2020 European Research Council, Medizinischen Fakultät, Eberhard Karls Universität Tübingen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Jürgen Manchot Stiftung
- H2020 European Research Council
- Medizinischen Fakultät, Eberhard Karls Universität Tübingen
Zitieren
APA
Antony, J. S., Haque, A. A., Lamsfus-Calle, A., Daniel-Moreno, A., Mezger, M., & Kormann, M. S. (2018). CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases. Advances in Cell and Gene Therapy. https://doi.org/10.1002/acg2.10
Vancouver
Antony JS, Haque AA, Lamsfus-Calle A, Daniel-Moreno A, Mezger M, Kormann MS. CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases. Advances in Cell and Gene Therapy. 2018. doi:10.1002/acg2.10
BibTeX
@article{Antony2018,
author = {Antony, Justin S. and Haque, A.K.M. Ashiqul and Lamsfus-Calle, Andrés and Daniel-Moreno, Alberto and Mezger, Markus and Kormann, Michael S.D.},
title = {CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases},
journal = {Advances in Cell and Gene Therapy},
year = {2018},
doi = {10.1002/acg2.10}
}
EUVIMED